SPARC files quarterly dematerialisation confirmation certificate

Compliance View source PDF Explain this filing

SPARC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.6%Reaction day

₹196.90

prior close

₹197.17

announcement price

In-mkt

timing

Nifty Microcap 250market-0.2%+0.8% vs market

Pharmaceuticals peers, median of 170sector-0.3%+0.9% vs sector

On the reaction day the stock moved 0.8 pts more than Nifty Microcap 250 and 0.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.2

15m

+0.3

30m

+1.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.6-0.2+0.8-0.3+0.9

Next day

-4.5-3.0-1.5-2.7-1.8

-5.1-2.7-2.3-2.7-2.4

-6.5-1.9-4.6-2.6-3.9

-3.9-1.7-2.2-3.0-0.9

-2.5-1.0-1.5-3.0+0.5

-3.5-2.0-1.6-3.5-0.1

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sun Pharma Advanced Research Company (SPARC) submitted a Confirmation Certificate under SEBI Regulation 74(5) for the quarter ended September 30, 2026. The certificate, issued by Registrar MUFG Intime, confirms that securities received for dematerialisation were processed and listed on stock exchanges within prescribed timelines. This is a routine compliance filing with no business impact.

Likely market impact

Routine regulatory compliance filing. No material impact on shareholders or stock price.